CClinicalTrials.gg
CompletedNCT03267914Updated Nov 24, 2021

Impact of Compliance With Fluoride Use on Caries Incidence After Cancer Therapy

An interventional study of Tray and Brush in Dental Caries, Oral Cavity Cancer and Oral Complications of Chemotherapy and Head/Neck Radiation, sponsored by A.T. Still University of Health Sciences. Completed at 1 site in United States. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2021-11-24.

Sponsored by A.T. Still University of Health Sciences · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

Approximately 40 people will participate in this study. This study will compare two different methods of fluoride application. Both methods are currently used in dental practice and both have been shown to be effective. If the participant chooses to participate in this study, participant will be asked to either wear a small tray that has been custom made to fit into the mouth into which fluoride is placed and worn for 5 minutes at bedtime, or participant will be asked to brush fluoride onto the teeth for 2 minutes at bedtime. Participant will be randomly assigned to use one of these methods of fluoride application: participant will not be allowed to choose which method of application you prefer. Participant will be asked to use fluoride every night while enrolled in the study. The fluoride that is used in the study is approved by the United States Food and Drug Administration and is commercially available with a prescription. After the study is over, participant will need to continue to use fluoride every night for life to help reduce the risk for dental cavities in the future.

During the study, participant will receive a dental examination every 3 months for a total of 4 study visits over the period of 1 year. This visit will consist of a dental examination to identify any new cavities and instructions for fluoride use. Participant will also be asked to complete a written log to document daily fluoride use and to give feedback about compliance with fluoride use.

Read the detailed description

This research proposal is unique in that it compares two different methods of applying neutral sodium fluoride to prevent dental caries and improve compliance in this at-risk population. Given that compliance with use of fluoride trays has historically been poor, there is controversy as to which application method is best. Further, the optimal dosage regimen is unknown. Clarification is needed to support best practices.

Data from the proposed study will help to identify an effective and tolerated form of fluoride delivery in patients undergoing head and neck radiation therapy. If our hypotheses are supported, additional studies will be undertaken with a larger sample size, and expanded to include patients with head and neck cancers treated with chemotherapy or a combination of cancer therapies.

All patients will undergo an initial dental visit, which will consist of medical consultation with the patient's oncologist and standard dental and radiographic examinations. Patients will return to have existing dental disease treated (eg. caries, gingival disease, extractions). When treatment is complete, they will be invited to participate in the study. The Screening Form will be used to confirm eligibility.

Study Visit #1 (Baseline) After obtaining consent, subjects will be randomly assigned to receive fluoride therapy with either custom trays (Tray group) or by application with a toothbrush (Brush group). Each subject will undergo a basic dental examination for identification of new carious lesions. Visit #1 is the baseline, with a new caries score of zero. Photographs will be taken of the subject's mouth and instructions for fluoride therapy will be given.

Tray group: The subject will have custom vinyl vacuform fluoride trays made using an in-house laboratory. They will be instructed to apply a "ribbon" of fluoride gel into each tray, and then to wear each tray for 5 minutes, one tray at a time, after which the subject will expectorate any remaining fluoride from the mouth.

Brush group: The subject will be instructed to apply a "ribbon" of fluoride gel onto the toothbrush provided (Colgate Wave Sensitive) and to brush with the fluoride for 2 minutes at bedtime.

Both groups: The subject may not rinse, eat, or drink for 30 minutes after the fluoride treatment.

All subjects will be instructed to perform their fluoride therapy at bedtime and to document the date and time of treatment on the Monthly Fluoride Log. All subjects will be provided with 1.1% neutral sodium fluoride (PreviDent®) gel for the duration of the study. All subjects will be instructed to return their monthly fluoride logs and any remaining fluoride at each study visit.

Subjects will return for a follow-up examination at 3, 6, 9, and 12 months from the first study visit. At each visit, the following procedures will be conducted:

  • Update medical history
  • Take photographs
  • Conduct examination for caries
  • Assess compliance with fluoride therapy
  • Collect fluoride log for previous 3 months
  • Dispense new fluoride log
  • Collect and weigh returned fluoride tube
  • Weigh and dispense new fluoride tube
  • Dispense new toothbrush (Brush group only)

Subjects will be scheduled to immediately return to have any new carious lesions filled.

To evaluate compliance, subjects will be asked about their fluoride use according to standard methods utilized by other experts in the field. High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.

To evaluate caries incidence, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay). Bitewing radiographs and periapical films (as needed) will be taken at 6 and 12 months after the initial examination visit.

Descriptive statistics, including means (standard deviations) or counts (percentages), as appropriate, will be used to summarize baseline demographic and clinical characteristics of the two groups.

02

Conditions studied

  • Dental Caries
  • Oral Cavity Cancer
  • Oral Complications of Chemotherapy and Head/Neck Radiation
03

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18 years and older
  • Diagnosis of cancer in the head and neck region
  • Field of radiation must include the parotid gland(s) and/or submandibular gland region
  • Able to speak English
  • Able to provide consent
  • Able to return for all study visits

Exclusion criteria

Exclusion Criteria:

  • Previous/current use of prescription strength fluoride
  • Previous history of radiation to the head and neck region
  • Presence of autoimmune disease(s)
  • Currently pregnant
  • Currently edentulous or will become edentulous prior to beginning radiation therapy
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Tray group

    Control intervention Patients will use the custom-made tray to apply the fluoride locally to the teeth and wear for 5 minutes each day.

    Other: Tray

  • Active comparator
    Brush group

    Patients will brush with the fluoride for 2 minutes each day.

    Other: Brush

Interventions

  • OtherTray

    Control intervention Patients will use the custom-made tray to apply the fluoride locally to the teeth and wear for 5 minutes each day.

  • OtherBrush

    Patients will brush with the fluoride for 2 minutes each day.

05

What researchers measure

Primary outcomes

  1. Fluoride use compliance

    To evaluate compliance, subjects will be asked about their fluoride use according to methods described by Epstein et al. (1996). High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.

    Time frame: 3 months

  2. Fluoride use compliance

    To evaluate compliance, subjects will be asked about their fluoride use according to methods described by Epstein et al. (1996). High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.

    Time frame: 6 months

  3. Fluoride use compliance

    To evaluate compliance, subjects will be asked about their fluoride use according to methods described by Epstein et al. (1996). High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.

    Time frame: 9 months

  4. Fluoride use compliance

    To evaluate compliance, subjects will be asked about their fluoride use according to methods described by Epstein et al. (1996). High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.

    Time frame: 12 months

Secondary outcomes

  1. Dental caries incidence assessed at 4 time points

    To evaluate caries incidence clinically, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay).

    Time frame: 3 months

  2. Dental caries incidence assessed clinically at 4 time points

    To evaluate caries incidence clinically, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay).

    Time frame: 6 months

  3. Dental caries incidence assessed at 4 time points

    To evaluate caries incidence clinically, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay).

    Time frame: 9 months

  4. Dental caries incidence assessed at 4 time points

    To evaluate caries incidence clinically, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay).

    Time frame: 12 months

Other outcomes

  1. Dental caries incidence assessed radiographically at 2 time points

    To evaluate caries incidence radiographically, bitewing radiographs and periapical films (as needed) will be taken at 6 and 12 months after the initial examination visit.

    Time frame: 6 months

  2. Dental caries incidence assessed radiographically at 2 time points

    To evaluate caries incidence radiographically, bitewing radiographs and periapical films (as needed) will be taken at 6 and 12 months after the initial examination visit.

    Time frame: 12 months

06

Study locations

1 site
  • A.T. Still University, Arizona School of Dentistry & Oral Health
    Mesa, Arizona 85206, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03267914
Lead sponsor
A.T. Still University of Health Sciences
Responsible party
Seena Patel (Dentist, Associate Director of Oral Medicine and Assistant Professor, A.T. Still University of Health Sciences) — Principal investigator
First posted
Aug 31, 2017
Start date
Aug 29, 2017
Primary completion
Nov 22, 2021
Completion
Nov 22, 2021
Last update
Nov 24, 2021

Study contacts

Seena Patel, DMD, MPH
principal investigator · A.T. Still University, Arizona School of Dentistry & Oral Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion